GlassScriptPhysician profile
Ashim Aggarwal
NPI 1558553016
$47,198.46
in general payments reported to CMS, 2019-2025
42 companies · $3,188 in 2025
The $3,188 reported for 2025 was more than what 76% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,522 · 2020: $3,339 · 2021: $17K · 2022: $11K · 2023: $4,593 · 2024: $4,973 · 2025: $3,188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Travel and Lodging: $831.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,923.14 |
| Travel and Lodging | $830.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $31,159.01 | 2019-2025 | Cardiomems, Gallant, Mitraclip |
| Boston Scientific Corporation | $5,365.37 | 2019-2025 | Watchman, Lux-Dx Insertable Cardiac Monitor, Watchman Flx |
| Medtronic, INC. | $1,667.04 | 2021-2024 | Micra, Resolute Onyx, Azure Xt Dr Mri Surescan |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,468.45 | 2019-2025 | Lifevest |
| Amgen INC. | $1,177.76 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $931.00 | 2020-2025 | |
| Edwards Lifesciences Corporation | $830.83 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Pascal |
| Merck Sharp & Dohme LLC | $495.98 | 2021-2025 | Verquvo, Capvaxive |
| Philips North America LLC | $467.30 | 2022-2024 | (5091) Amb Mon & Diag Und |
| Boehringer Ingelheim Pharmaceuticals, INC. | $462.60 | 2023-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $399.54 | 2019-2025 | Farxiga |
| Actelion Pharmaceuticals US, INC. | $298.06 | 2021-2025 | Opsumit, Uptravi |
| Penumbra, INC. | $281.32 | 2022-2024 | Indigo System |
| Pfizer INC. | $193.59 | 2019-2024 | |
| W. L. Gore & Associates, INC. | $168.57 | 2023 | Gore Viabahn Endoprosthesis |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $165.13 | 2022-2025 | Assure Wcd |
| Sanofi-Aventis U.S. LLC | $164.86 | 2021-2023 | |
| Abiomed | $147.71 | 2022 | |
| Impulse Dynamics (USA) INC. | $145.69 | 2022 | |
| Bardy Diagnostics, INC. | $135.00 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $109.11 | 2019-2021 | |
| Cardiva Medical, INC. | $104.48 | 2024 | Optowire |
| Cleerly, INC. | $98.79 | 2025 | Cleerly Ischemia, Cleerly Labs |
| E.R. Squibb & Sons, L.L.C. | $91.49 | 2022-2025 | Eliquis, Camzyos |
| Baxter Healthcare | $89.39 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Acutus Medical, INC. | $84.58 | 2022 | |
| Heartflow, INC. | $81.81 | 2025 | |
| Cardiovascular Systems INC. | $74.39 | 2020 | |
| Angiodynamics, INC. | $51.31 | 2022-2024 | Auryon Laser System 100-120 Vac |
| Lexicon Pharmaceuticals, INC. | $29.96 | 2023-2024 | Inpefa |
| Medtronic Vascular, INC. | $28.15 | 2020 | |
| Tactile Systems Technology INC | $25.97 | 2021-2023 | Flexitouch Plus, Entre Plus |
| Abbvie INC. | $25.88 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $23.87 | 2021 | |
| Inspire Medical Systems, INC. | $22.90 | 2025 | Inspire |
| Glaxosmithkline, LLC. | $22.83 | 2025 | Shingrix, Arexvy |
| Amarin Pharma, INC. | $20.98 | 2021 | |
| Novo Nordisk INC | $20.78 | 2024 | Wegovy |
| Zoll Respicardia, INC. | $20.23 | 2024 | Remede System |
| Alnylam Pharmaceuticals INC. | $17.28 | 2024 | Amvuttra |
| Kiniksa Pharmaceuticals, LTD. | $14.89 | 2023 | Arcalyst |
| Kiniksa Pharmaceuticals International, Plc | $14.58 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashim Aggarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.